Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	13,503	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	18.04%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	16,741	11,901	9,264	5,237	4,683	5,412
Last Close Price	3.16	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	3.01	2.18	3.75	0.93	0.98	1.09
PB Ratio	8.17	5.92	3.27	3.49	2.43	2.35
P/TBV Ratio	8.27	5.99	3.27	3.49	2.43	2.35
P/FCF Ratio	-	-	-	-	-	1693.09
P/OCF Ratio	34.08	24.70	-	20.49	-	9.61
EV/Sales Ratio	3.73	2.65	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	8.53	6.07	21.81	54.54	49.41	8.47
EV/EBIT Ratio	9.14	6.50	31.01	-	-	9.86
EV/FCF Ratio	-54.58	-	-	-	-	2756.94
Debt / Equity Ratio	3.26	3.26	1.73	4.68	3.05	2.15
Debt / EBITDA Ratio	2.74	2.74	10.33	35.20	35.15	4.64
Debt / FCF Ratio	-	-	-	-	-	1551.72
Asset Turnover	0.41	0.41	0.27	-	0.43	0.48
Inventory Turnover	1.30	1.30	0.79	-	1.02	1.12
Quick Ratio	0.35	0.35	0.45	0.48	0.63	1.53
Current Ratio	0.58	0.58	0.76	1.00	1.24	2.28
Return on Equity (ROE)	-42.27%	-42.27%	-108.42%	-	-8.74%	20.13%
Return on Assets (ROA)	10.33%	10.33%	2.24%	-	-0.24%	5.41%
Return on Capital (ROIC)	16.40%	16.40%	3.29%	-	-0.35%	7.60%
Return on Capital Employed (ROCE)	85.50%	85.50%	9.80%	-	-	13.20%
Earnings Yield	-6.56%	-9.05%	-21.68%	-11.97%	-4.12%	8.14%
FCF Yield	-2.27%	-3.13%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-	-	-125.00%	-	-	-
Total Shareholder Return	-	-	-125.00%	-	-	4.17%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.